Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Beta Human Chorionic Gonadotropin Quantitative

Immunology & Autoimmune

hCG beta quantitativeQuantitative pregnancy test (serum)β-hCG

Review status

Currently under review

Pending specialist review and validation.

What it shows

This blood test measures the amount of beta human chorionic gonadotropin, a hormone produced soon after a fertilized egg attaches to the uterine lining. The test detects and quantifies the hormone in your blood. Unlike a simple yes or no test, a quantitative result shows how much hormone is present.

Beta hCG is most commonly used to help detect and monitor early pregnancy. It can also be measured to follow the course of a pregnancy concern, after a pregnancy event, or in certain medical conditions where small amounts may be present even when you are not pregnant.

Why it matters

Your clinician may order this test to confirm pregnancy, to monitor how a pregnancy is progressing, or to help evaluate symptoms such as bleeding or pain in early pregnancy. Changes in levels over time can provide useful clues alongside your history, exam, and imaging.

Outside of pregnancy, this test may be used to monitor recovery after a pregnancy event or a specific placental condition, and in some cases to help evaluate certain tumors that can produce the hormone. Understanding why the test was ordered in your situation helps guide what results mean and what follow-up is appropriate.

Understanding your results

Results are interpreted in context. A single value offers a snapshot, while repeating the test over short intervals shows a trend. Rising levels in early pregnancy are expected, while stable or falling patterns may prompt your clinician to consider other explanations. Your provider may compare the pattern with ultrasound findings to decide next steps.

If you are not pregnant, very low or undetectable levels are typical. Slight detectable results can occur for several reasons, including timing after a recent pregnancy event, certain medications, or rarely from your own pituitary gland or specific tumors. If a result does not fit your situation, your clinician may repeat testing, use a different assay, or order additional tests to clarify the picture.

Reference ranges

04.9 IU/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Beta Human Chorionic Gonadotropin Quantitative

  • Timing of testing

    Very early after conception, levels may be below detection. Testing again after a short interval often clarifies results, especially if the first result is unexpected.

  • Recent pregnancy events

    After childbirth, miscarriage, abortion, or treatment of a pregnancy-related condition, levels can take time to return to baseline. Residual hormone may be seen for a period.

  • Fertility treatments and medications

    Injections used to trigger ovulation contain the same hormone and can cause a temporary positive result. Tell your clinician about any fertility drugs or supplements.

  • Assay interference

    Rare antibodies in your blood, high-dose biotin supplements, or very high hormone levels can interfere with some methods. Laboratories can use alternative methods or blocking agents if needed.

  • Menopause and pituitary sources

    Low-level production from the pituitary gland can occur in perimenopause and menopause. Your clinician may use clinical context or additional tests to interpret small results.

  • Certain tumors

    Some germ cell and placental tumors can produce this hormone. When pregnancy is excluded, persistent or rising results may prompt focused evaluation.

2026

References

  1. McGill University Health Centre. (2015, July 02). Beta Human Chorionic Gonadotropin Quantitative (Task CD 684743). Laboratory reference ranges.
  2. American College of Obstetricians and Gynecologists. (2018). ACOG Practice Bulletin No. 193: Tubal ectopic pregnancy. Obstetrics & Gynecology, 131(3), e91–e103.
  3. National Institute for Health and Care Excellence. (2019, updated 2023). Ectopic pregnancy and miscarriage: Diagnosis and initial management (NICE Guideline NG126). External link
  4. U.S. Food and Drug Administration. (2019). The FDA warns that biotin may interfere with lab tests: FDA safety communication. External link